5
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Treatment of “Limited” Stage III Non-Small Cell Carcinoma of the Lung

, , , &
Pages 193-207 | Published online: 11 Jun 2009

References

  • Silverberge E. Cancer Statistics, 1984. CA: A Cancer Journal for Clinicians 1984; 4: 7–23
  • Martini N, McCormack P. Therapy of stage III (nonmetastatic disease). Sem Oncol 1983; 10: 95–110
  • American Joint Committee for Cancer Staging and End Results Reporting. 1977, Manual for Staging of Cancer, Chicago
  • Martini N, Flehinger B J, Zernan M B, et al. Prospective study of 445 lung carcinomas with mediastinal lymph node metastases. J Thorac Cardiovasc Surg 1980; 80: 90–399
  • Cox J D, Byhardt R W, Komaki R. The role of radiotherapy in squamous, large cell and adenocarcinomas of the lung. Sem Oncol 1983; 10: 81–93
  • Eagan R T, Lee R, Frytak E. S, et al. Thoracic radiation therapy and udriumycin/cisplatin containing chemotherapy for locally advanced non-small cell lung cancer. Cancer Clin Trials 1981; 2: 381–388
  • Komaki R K, Cox J D, Hartz A J, et al. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung. Am J Clin Oncol (CCT) 1985; 8: 362–370
  • McCaughan B C, Martini N, Bains M S, et al. Chest wall invasion in carcinoma of the lung. J Thorac Cardiovasc Surg 1983; 89: 836–841
  • Trastek V F, Pairolero P C, Piehler J M, et al. En bloc (non-chest wall) resection for bronchogenic carcinoma with pariet al fixation. J Thorac Cardiovasc Surg 1984; 87: 352–358
  • Piehler J H, Pairolero P C, Weiland L H, et al. Bronchogenic carcinoma with chest wall invasion: factors effecting survival Mowing en bloc resection. Ann Thorac Surg 1982; 34: 684–691
  • Komaki R, Roh J, Cox J D, et al. Superior sulcus Tumors: Results of irradiation in 36 patients. Cancer 1981; 48: 1563–1568
  • Paulson D L. Combined preoperative irradiation and extended resection for carcinoma in the superior pulmonary sulcus. Management of Superior Pulmonary Sulcus Syndrome (Pancoast Syndrome), J J Bonica, V Venta-Fridda, C A Pagni. Raven Press, New York 1982; 47–63, Advances in Pain Research and Therapy
  • Eschapasse H. Sleeve lobectomy for carcinoma of the lung. Proceedings of the Mini-Symposia of the Fourth World Conference on Lung Cancer, TorontoCanada, August, 25–30, 1985; 52–53
  • Jensik R J. Indications for sleeve resection in tumors involving the main bronchus of the distal trachea. Presented at the World Conference on Lung Cancer (International Association for the Study of Lung Cancer), Hilton Head, South Carolina, 1978
  • Leff A, Hopewell P C, Costello J. Pleural effusion from malignancy. Ann Intern Med 1978; 88: 532–537
  • Decker D A, Dines D E, Payne W S, et al. The significance of cytc-logically negative pleural effusion on bronchogenic carcinoma. Chest 1978; 74: 640
  • Sawamura K, Mori T, Hashimoto S, et al. Results of surgical treatment for N] disease. IV World Conference on Lung Cancer (Abstr). 1985; 43
  • Kaplan E L, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
  • Ginsburg R J. The Lung Cancer Study Group Experience. Proceedings of the Mini-Symposia of the Fourth World Conference on Lung Cancer, TorontoCanada, 1985; 144–145
  • Holmes E C, Gail M. Surgical adjuvant therapy for stage II and stage HI adenocarcinoma and large cell undifferentiated carcinoma. J Clin Onol 1986; 4: 710–715
  • Bitran J D, Golomb H M, Hoffman P G, et al. Protochemotherapy in non-small cell lung cancer. Cancer 1986; 57: 44–53
  • Skarin A, Veeder M, Malcolom A. Chemotherapy (CAP) prior to radiotherapy (RT) and surgery in marginally resectable non-small cell lung cancer (NSCCLQ. Proc ASCO 1982; 1: 143
  • Trybula M, Taylor S G, IV, Bonomi P. Preoperative simultaneous cisplatin, 5-fluorouracil, and radiotherapy in clinical stage III, non-small cell bronchogenic carcinoma. Proc ASCO 1984; 3: 223
  • Bromley L L, Szur L. Combined radiation therapy and resection for carcinoma of the bronchus: experiences win 66 patients. Lancet 1955; 2: 937–941
  • Bloedorn F G, Cowley R A, Cuccia C A. Preoperative irradiation in bronchogenic carcinoma. Am J Roentgenol Rad Ther Nuclear Med 1964; 92: 77–87
  • Smart J. Can lung cancer be cured by radiation alone. J Am Med Assoc 1966; 159: 1034–1035
  • Roswit B, Patno M E, Rapp R, et al. The survival of patients with inoperable lung cancer: A large scale randomized trial of radiation therapy vs. placebo. Radiology 1968; 96: 688–697
  • Scanlon P W. The effect of mitotic suppression and recovery after radiation on time dose relationships and the application of this effect to clinical radiation therapy. Am J Roentgenol Rad Ther Nuclear Med 1959; 81: 433–455
  • Holsti L R. Alternative approach to radiotherapy alone and radiotherapy as a part of a combined therapeutic approach for lung cancer. Cancer Chemother Rep 1983; 165–169, Part HI (24)
  • Levitt S H, Bogardus C R, Ladd G. Split-dose intensive radiation therapy in the treatment of advanced lung cancer: A Randomized Study. Radiology 1967; 88: 1159–1161
  • Abramson Cavanaugh P J. Short course radiation therapy in carcinoma of the lung. Radiology 1970; 96: 627–630
  • Carr D T, Quids D S, Lee R E. Radiotherapy plus 5-FU compared with radiology alone for inoperable and unresectable bronchogenic carcinoma. Cacner 1972; 29: 375–380
  • Sealy Lagakos R. S, Barkely T, et al. Radiotherapy of regional epidermoid carcinoma of the lung. Cancer 1982; 49: 1338–1345
  • Petrovich Z, Stanley K, Cox J D, et al. Radiotherapy in the management of locally advanced lung cancer of all cell types. Cancer 1981; 48: 1335–1340
  • Perez C A, Rubin P, Frances M, et al. Patterns of failure in localized unresectable non-oat cell carcinoma of the lung treated by radiation therapy (abstr). Proc ASCO-AACR 1984; 3: 231
  • Perez C A. Non-small cell carcinoma of the lung: Dose-time parameters. Cancer Treat Symp 1985; 2: 131–142
  • Lee R E. Radiotherapy of bronchogenic carcinoma. Sem Oncol 1974; 1: 245–251
  • Hilaris B S. Brachytherapy in lung cancer. Proceedings of the Mini-Symposia of the Fourth World Conference on Lung Cancer, TorontoCanada, August, 25–30, 1985; 136–137
  • Sealy R. Combined radiotherapy and chemotherapy in non-small cell carcinoma of the lung. Lung Cancer: Progress in Therapeutic Research, F M Muggia, M Rozencweig. Raven Press, New York 1979; 315–323
  • Bleehen N M. Management of inoperable squamous cell, adeno and large cell carcinomas. Lung Cancer, 1980, H H Hansen, M Rorth. Exerpta Medica, Amsterdam 1980; 93–112
  • Chan P YM, Byfield J E, Kazan A R, et al. Unresectable squamous cell carcinoma of the lung and its management by combined bleomycin and radiotherapy. Cancer 1976; 37: 2671–2676
  • Madel P J, Bitran J D, Golomb H M, et al. Combined modality therapy for stage III M0 non-small cell lung cancer. Cancer 1984; 54: 5–12
  • Eagan R T, Lee R E, Frytak S, et al. Current results of combined modality therapy in unresectable lung cancer. Proceedings, MD Anderson Clinical Conference on Cancer. November, 7–9, 1984
  • Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 1973; 4: 31–42
  • Lee R E, Carr D T, Childs D S, Jr. Comparison of split-course radiation therapy and continuous radiation therapy for unresectable bronchogenic carcinoma: Five year results. Am J Reoentgenol Rad Ther Nuclear Med 1976; 126: 116–122
  • Cox J D, Stanley K, Petrovich Z, et al. Cranial irradiation in cancer of the lung of all cell types. J Am Med Assoc 1981; 245: 469–472
  • Cohen L. New modalities in radiotherapy of lung cancer. Proceedings of the Mini-Symposia of the Fourth World Conference on Lung Cancer, TorontoCanada, 1985; 138–139
  • Seydel H G. Use of altered fractionation schedules. Proceedings of the Mini-Symposia of the Fourth World Conference on Lung Cancer, TorontoCanada, 1985; 140–141
  • Turrisi A T, Glover D L, Mason B. Acute toxicity of twice daily radiotherapy (2X/D XRT) and concurrent cis-platinum/VP-16 chemotherapy (DDP/VP-16) in limited small cell lung cancer (LTD-SCLQ. Conference Program and Abstracts. Fourth World Conference on Lung Cancer, TorontoCanada, 1985; 112
  • Lung Cancer Study Group: The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer, prepared by T Lad, L Rubinstein, and A Sadeghi. J Clin Oncol 1988; 6(1)9–17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.